<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dermoscopic evaluation of skin lesions</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dermoscopic evaluation of skin lesions</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Dermoscopic evaluation of skin lesions</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ashfaq A Marghoob, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Natalia Jaimes, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hensin Tsao, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H18480288"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Dermoscopy is a noninvasive in vivo technique used for the examination of lesions and diseases involving the glabrous and nonglabrous skin as well as abnormalities involving the hair and nails. Dermoscopy, dermatoscopy, epiluminescence microscopy, incident light microscopy, and skin-surface microscopy are synonyms. Dermoscopy is performed with a handheld instrument called a dermatoscope. The procedure allows for the visualization of subsurface skin structures in the epidermis, dermoepidermal junction, and superficial dermis, which are generally not visible to the naked eye [<a href="#rid1">1-3</a>].</p><p>The general principles of dermoscopy; dermoscopic structure terminology; dermoscopic evaluation of skin lesions; and dermoscopic evaluation of facial, mucosal, and acral volar skin lesions are discussed separately. Dermoscopy of nail pigmentation and dermoscopic algorithms for skin cancer triage are also discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13521.html" rel="external">"Overview of dermoscopy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/93602.html" rel="external">"Dermoscopy of facial lesions"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/93603.html" rel="external">"Dermoscopy of mucosal lesions"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16551.html" rel="external">"Dermoscopy of pigmented lesions of the palms and soles"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/100032.html" rel="external">"Dermoscopy of nail pigmentations"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/100084.html" rel="external">"Dermoscopic algorithms for skin cancer triage"</a>.)</p><p></p><p class="headingAnchor" id="H961068537"><span class="h1">PRINCIPLES OF DERMOSCOPIC DIAGNOSIS</span><span class="headingEndMark"> — </span>The dermoscopic diagnosis of skin lesions involves the recognition of the presence or absence of specific structures to confirm or rule out a given diagnosis. From a cognitive perspective, this task may be accomplished using a bottom-up or a top-down strategy. In the bottom-up strategy, the observer performs a visual search for salient details (individual features) to arrive at a diagnosis, whereas in the top-down strategy, the observer recognizes the general context, generates a hypothesis of the likely clinical diagnosis, and performs a targeted dermoscopic search for specific features to confirm or negate the presumed clinical diagnosis [<a href="#rid4">4</a>].</p><p>This topic will review several algorithms and scoring systems that predominantly use a top-down strategy to assist clinicians in the decision-making process as to whether a lesion needs to be biopsied.</p><p class="headingAnchor" id="H19871422"><span class="h1">PATTERN ANALYSIS: THE REVISED TWO-STEP ALGORITHM FOR SKIN LESION EVALUATION</span></p><p class="headingAnchor" id="H566689170"><span class="h2">Overview</span><span class="headingEndMark"> — </span>The two-step pattern analysis algorithm forms the foundation for the dermoscopic evaluation of skin lesions. It was first introduced by the panel of the Consensus Internet Meeting on Dermoscopy in 2003 and has since undergone several modifications [<a href="#rid5">5-7</a>].</p><p>The original two-step algorithm required lesions to be classified as melanocytic (nevus versus melanoma) or as nonmelanocytic  (<a class="graphic graphic_algorithm graphicRef62532" href="/d/graphic/62532.html" rel="external">algorithm 1</a>). The requirement to classify lesions as melanocytic (based on the presence of network; streaks; angulated lines; negative network; aggregated globules; homogeneous, blue color; pseudonetwork on facial skin; or parallel pattern on volar lesions) came under criticism since some nonmelanocytic lesions may reveal features resembling the aforementioned structures, and on rare occasions, melanomas may lack these structures [<a href="#rid8">8</a>]. Although a subsequent study provided evidence validating the first step [<a href="#rid9">9</a>], the authors of this topic introduced a modification of the two-step process to address the criticisms and to amalgamate new insights regarding the morphology of benign and malignant lesions.</p><p>The updated top-down approach discussed here uses pattern analysis and builds upon the previous two-step algorithm while combining it with concepts derived from the triage amalgamated dermoscopy algorithm (see  <a class="medical medical_review" href="/d/html/100084.html" rel="external">"Dermoscopic algorithms for skin cancer triage"</a>). The revised version of the two-step algorithm  (<a class="graphic graphic_algorithm graphicRef140579" href="/d/graphic/140579.html" rel="external">algorithm 2</a>) eliminates the former requirement to differentiate melanocytic from nonmelanocytic lesions in the first step [<a href="#rid6">6,10,11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Step 1</strong> – In the new approach, the observer is required to make a specific diagnosis by recognizing the patterns associated with common, benign neoplasms (eg, nevi, lentigines, seborrheic keratoses, angiomas)  (<a class="graphic graphic_algorithm graphicRef140580" href="/d/graphic/140580.html" rel="external">algorithm 3</a>). If an unequivocal diagnosis of one of the benign lesions cannot be made with confidence, then the lesion under evaluation will proceed to step 2.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Step 2</strong> – In step 2, the observer will determine if the overall pattern of the lesion (ie, distribution of colors and structures) is organized or disorganized  (<a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>). Lesions displaying a disorganized pattern (ie, asymmetric or chaotic) are evaluated in step 2a, and lesions manifesting an organized pattern are evaluated in step 2b:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Step 2a</strong> – Lesions displaying a disorganized pattern have a high likelihood of being malignant, and based on the presence of specific structures, these lesions can usually be subclassified as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or melanoma.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Step 2b</strong> – Lesions that are organized are likely benign. However, organized lesions displaying any of the following should still raise concern for malignancy: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Starburst pattern</p><p class="bulletIndent3"><span class="glyph">-</span>Negative network pattern</p><p class="bulletIndent3"><span class="glyph">-</span>Vessels</p><p class="bulletIndent3"><span class="glyph">-</span>Ulceration</p><p class="bulletIndent3"><span class="glyph">-</span>Blue-black, gray, or white color</p><p></p><p class="headingAnchor" id="H19871430"><span class="h2">Step 1: Benign lesions</span><span class="headingEndMark"> — </span>In the first step of the revised two-step pattern analysis algorithm  (<a class="graphic graphic_algorithm graphicRef140579" href="/d/graphic/140579.html" rel="external">algorithm 2</a>), the observer is required to make a specific diagnosis by recognizing patterns associated with common, benign skin lesions (eg, nevi, dermatofibromas, intradermal nevi, seborrheic keratoses/solar lentigo, angiomas, sebaceous hyperplasias). This list of benign lesions can be expanded upon depending on the observer's experience in recognizing less common, benign lesions, such as clear cell acanthoma  (<a class="graphic graphic_picture graphicRef141522" href="/d/graphic/141522.html" rel="external">picture 1</a>), poroma, and xanthogranuloma.</p><p>Although benign lesions tend to display an overall organized pattern, individual lesions require a contextualized interpretation that considers size and location of the lesion, the patient's age, and lesion history. As an example, a lesion with features of a seborrheic keratosis located on the palm should raise concern since seborrheic keratoses do not normally develop on volar surfaces.</p><p class="headingAnchor" id="H2912961226"><span class="h3">Acquired nevi and small congenital nevi</span><span class="headingEndMark"> — </span>Acquired and small congenital nevi can be of multiple subtypes (eg, junctional; compound; Spitz, Reed, Clark nevi). Although most of these nevi display an organized pattern, each one requires interpretation considering contextual features, such as history, size, patient age, skin phenotype, anatomical location, and whether the lesion is an outlier (ugly duckling). Outlier nevi are those that do not adhere to the signature nevus pattern displayed by the other nevi in the patient.</p><p>Overall, there are three dermoscopic structures that form recognizable patterns (ie, network, globules, and homogeneous areas). Their combinations result in different benign patterns observed  (<a class="graphic graphic_figure graphicRef61160" href="/d/graphic/61160.html" rel="external">figure 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diffuse network/reticular pattern and patchy network/reticular pattern</strong> – These patterns consist of an organized network composed of lines that have minimal variation in color and thickness. The holes of the network also appear relatively homogeneous in size. The network tends to have shades of brown and rarely displays gray or black color. The network tends to fade toward the periphery. The diffuse, reticular pattern is commonly seen in melanocytic nevi with a prominent, junctional component (ie, junctional nevi, superficial congenital nevi)  (<a class="graphic graphic_picture graphicRef54776" href="/d/graphic/54776.html" rel="external">picture 2</a>).</p><p></p><p class="bulletIndent1">The patchy network pattern consists of focal network patches that are distributed in a symmetric and organized manner and separated by homogeneous, structureless areas that are of the same color or slightly darker than the background skin. The network patches all have the same type of network, with minimal variability in the thickness and color of the lines. This pattern is commonly seen in acquired melanocytic nevi and some congenital nevi  (<a class="graphic graphic_picture graphicRef62442" href="/d/graphic/62442.html" rel="external">picture 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation </strong>– Isolated, large, acquired, lentiginous lesions in older individuals located on sun-damaged skin with a network or patchy network pattern should raise suspicion since melanoma on sun-damaged skin (lentigo maligna type) can manifest this pattern [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peripheral network with central hypopigmentation or hyperpigmentation</strong> – The peripheral network is typical/regular in nevi exhibiting these patterns. In nevi with central hypopigmentation, the central portion consists of a homogeneous, hypopigmented, structureless area of the same color (or slightly darker) as the background skin. In nevi exhibiting central hyperpigmentation, the central area (blotch) often results from the accumulation of melanin-laden corneocytes in the stratum corneum (ie, lamella), which can usually be tape-stripped off, revealing an underlying typical network.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation</strong> – Skin phenotype. Central hypopigmentation  (<a class="graphic graphic_picture graphicRef57412" href="/d/graphic/57412.html" rel="external">picture 4</a>) is commonly seen in acquired melanocytic nevi in individuals with lightly pigmented skin  (<a class="graphic graphic_picture graphicRef78278" href="/d/graphic/78278.html" rel="external">picture 5</a>), whereas central hyperpigmentation is commonly seen in acquired melanocytic nevi in individuals with darkly pigmented skin  (<a class="graphic graphic_picture graphicRef57412" href="/d/graphic/57412.html" rel="external">picture 4</a>). Thus, lesions displaying central hypopigmentation in individuals with darkly pigmented skin and lesions with central hyperpigmentation in individuals with lightly pigmented skin should raise suspicion of melanoma [<a href="#rid13">13-15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Globular pattern (including peripheral network with central, brown globules) and globular nevi (including cobblestone globular nevi)</strong> – Globules of similar shape, size, and color are distributed throughout the lesion or in the center of the lesion with a regular peripheral network. Globules may be large and angulated, creating a cobblestone pattern as seen in dermal nevi and some congenital nevi  (<a class="graphic graphic_picture graphicRef67691" href="/d/graphic/67691.html" rel="external">picture 6</a>). On rare occasions, the globules can be white (as seen on balloon cell nevi). While black and blue globules can occasionally be seen in congenital nevi, their presence should raise suspicion for melanoma.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation</strong> – The globular pattern is commonly seen in congenital nevi  (<a class="graphic graphic_picture graphicRef80161" href="/d/graphic/80161.html" rel="external">picture 7</a>) most often located on the head/neck or torso. Thus, newly acquired lesions with a globular morphology occurring in an older individual, and especially if the lesion is located on an extremity, should raise concern for melanoma [<a href="#rid14">14,16,17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reticular pattern with peripheral globules</strong> – It consists of a typical network nevus with a peripheral rim of regular, brown globules  (<a class="graphic graphic_picture graphicRef55874" href="/d/graphic/55874.html" rel="external">picture 8</a>). This pattern is associated with the radial growth phase of Clark/dysplastic nevi and is commonly encountered in younger patients with atypical mole syndrome (see  <a class="medical medical_review" href="/d/html/13519.html" rel="external">"Atypical (dysplastic) nevi"</a>). On histopathology, nevi with one peripheral rim of globules usually correspond to dysplastic nevi with mild to moderate atypia, while nevi displaying a multitiered, peripheral, globular pattern usually correspond to dysplastic nevi with some degree of a spitzoid morphology [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation</strong> – Consider age and location. These nevi are most common on the torso of younger to middle-aged patients. Newly acquired lesions displaying peripheral globules should be viewed with suspicion if seen in older individuals, especially if the lesion is located on an extremity or reveals a melanoma-specific structure [<a href="#rid14">14,19-22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Starburst pattern</strong> – Consists of a darkly pigmented nevus with streaks at the perimeter of the lesion distributed in a symmetric fashion. This pattern is associated with Reed nevi that are in their radial growth phase  (<a class="graphic graphic_picture graphicRef55874" href="/d/graphic/55874.html" rel="external">picture 8</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation</strong> – Consider the patient's age. Although streaks can also be present in superficial spreading melanoma, melanomas are very rare in preadolescent individuals (see  <a class="medical medical_review" href="/d/html/101324.html" rel="external">"Melanoma in children"</a>). Thus, lesions with a starburst pattern seen in children have an extremely high pretest probability for being Reed nevi. In contrast, lesions with a starburst pattern in older individuals have a heightened pretest probability for melanoma [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Homogeneous, blue</strong> <strong>pattern</strong> – This pattern is the hallmark of blue nevus. The blue color should not be confused with a blue-white veil. In contrast to the blue-white veil, the blue color with white, veil-like appearance in blue nevi encompasses the entire lesion's surface with minimal variation in the blue hues  (<a class="graphic graphic_picture graphicRef69190" href="/d/graphic/69190.html" rel="external">picture 9</a>). If there are multiple hues (ie, heterogeneous, blue color or nonhomogeneous veil), the diagnosis of melanoma should be considered.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation</strong> – In patients with a previous history of invasive melanoma, epidermotropic metastasis, which can mimic blue nevi, should be ruled out [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Homogeneous, brown pattern</strong> – The nevus shows brown color with minimal to no variation in its hues. While it is usually devoid of any other structures, on rare occasions one can see a few regular dots/globules and fragments of network. This pattern is associated with small to medium congenital nevi  (<a class="graphic graphic_picture graphicRef69190" href="/d/graphic/69190.html" rel="external">picture 9</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation</strong> – Consider the patient's age. Since these nevi are usually present at birth or develop within the first few years of life and tend to be stable lesions, a newly acquired lesion in an adult demonstrating a homogeneous, brown pattern should be viewed with suspicion. Such lesions, if not palpable, can be digitally monitored and biopsied if they display change [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Homogeneous, tan/pink pattern</strong> –<strong> </strong>Nevi with homogeneous, tan/pink color are featureless or may display some vessels  (<a class="graphic graphic_picture graphicRef69190" href="/d/graphic/69190.html" rel="external">picture 9</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Key contextual interpretation</strong> – Consider skin phenotype. Since these nevi are seen predominantly in individuals with skin types I to II, a newly acquired nevus with a homogeneous, tan to pink color in individuals with darkly pigmented skin should raise concern for amelanotic or hypomelanotic melanoma. In addition, since amelanotic melanomas are also common in skin types I to II, it remains imperative that these lesions be evaluated in context with the other nevi present on the patient's skin. Outlier lesions should always raise suspicion for melanoma. If melanoma is in the differential diagnosis and the lesion is nonpalpable, then it can be subjected to digital monitoring. Lesions that are raised or manifest change on follow-up should be biopsied [<a href="#rid25">25,26</a>].</p><p></p><p class="headingAnchor" id="H4278199720"><span class="h3">Intradermal nevi and dermatofibroma (both palpable/raised lesions)</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intradermal nevi</strong> – Intradermal nevi display a characteristic clinical morphology consisting of a raised, dome-shaped, soft papule located on the face (Miescher nevi)  (<a class="graphic graphic_picture graphicRef96671" href="/d/graphic/96671.html" rel="external">picture 10</a>) or a sessile, mamillated papule located on the torso (Unna nevi)  (<a class="graphic graphic_picture graphicRef76961" href="/d/graphic/76961.html" rel="external">picture 11</a>). Intradermal nevi usually demonstrate preserved skin markings and may have hairs emanating from their surface.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical clues</strong>:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Typically, intradermal nevi have been present on the skin for many years, without any history of change or spontaneous bleeding.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The skin markings in an intradermal nevus tend to be preserved, whereas they are lost in BCC (resulting in BCCs having a shiny surface).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The presence of hair within the lesion is highly suggestive of an intradermal nevus.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dermoscopy clues</strong> (at least one) [<a href="#rid27">27-29</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Predominantly comma-shaped vessels or a polymorphous, vascular pattern with at least some comma-shaped vessels  (<a class="graphic graphic_picture graphicRef96283" href="/d/graphic/96283.html" rel="external">picture 12</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Brown halo</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Globules (including cobblestone-type globules)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Small foci of tan to brown, structureless pigment and/or hypopigmented areas</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dermoscopic clues to differentiate intradermal nevi from basal cell carcinoma</strong> – Differentiating intradermal nevi, especially Miescher type, from BCC can be challenging [<a href="#rid9">9</a>]. One of the main reasons for this is that, occasionally, intradermal nevi reveal arborizing-like vessels, which raise concern for BCC. However, clues that can assist in differentiating intradermal nevus from BCC include [<a href="#rid30">30</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Wobble test</strong> – Intradermal nevi wobble on dermoscopy, while BCC tend not to wobble [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Arborizing vessels</strong> – The extent of arborization tends to be much lesser in intradermal nevi than in BCC. In fact, in intradermal nevi, there may be only one arborizing point created by a "Y-shaped" vessel [<a href="#rid28">28</a>]. Furthermore, the vessels in BCC tend to be much sharper; in focus; and with a brighter, red color.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Shiny, white blotches and strands</strong> – On polarized dermoscopy, these structures are seen in BCC but not in intradermal nevi.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermatofibromas</strong> – Clinically, dermatofibromas present as firm papules  (<a class="graphic graphic_picture graphicRef80587" href="/d/graphic/80587.html" rel="external">picture 13</a>) that dimple on later pressure (ie, dimple sign  (<a class="graphic graphic_picture graphicRef80575" href="/d/graphic/80575.html" rel="external">picture 14</a>)). (See  <a class="medical medical_review" href="/d/html/5573.html" rel="external">"Overview of benign lesions of the skin", section on 'Dermatofibroma'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dermoscopy clues</strong>:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A symmetric lesion with a peripheral network and a central, white, scar-like area  (<a class="graphic graphic_picture graphicRef67214" href="/d/graphic/67214.html" rel="external">picture 15</a>). When viewed with polarized light, the central, scar-like area will usually manifest a pink hue and will also often reveal shiny, white lines.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Ring-like globules and vessels, which can be seen in the region between the network and the central, scar-like area.</p><p></p><p class="headingAnchor" id="H20440271"><span class="h3">Seborrheic keratoses and solar lentigo</span><span class="headingEndMark"> — </span>Most of the dermoscopic features of seborrheic keratoses are related to the papillomatous growth of the epidermis and the abundance of keratin in these tumors, and include  (<a class="graphic graphic_figure graphicRef78546" href="/d/graphic/78546.html" rel="external">figure 2</a> and <a class="graphic graphic_picture graphicRef78870" href="/d/graphic/78870.html" rel="external">picture 16</a> and <a class="graphic graphic_algorithm graphicRef140580" href="/d/graphic/140580.html" rel="external">algorithm 3</a>) [<a href="#rid32">32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermoscopy clues</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multiple milia-like cysts (three or more).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Comedo-like openings.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Moth-eaten borders.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gyri and sulci (also known as fissures and ridges) creating a cerebriform pattern. At times, these gyri and sulci can create a pattern resembling a network.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fingerprint-like structures. On rare occasions, these lines can be short and slightly curved ("U shaped"). It is interesting that when present, all of the "U-shaped" structures tend to be oriented in the same vectorial direction, resembling jelly that has been spread with a knife across a slice of bread (ie, jelly sign).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hairpin vessels surrounded by a white halo, which correspond to the capillary loops present in the dermal papilla.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sharp and well-demarcated borders</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Negative "wobble sign" [<a href="#rid31">31</a>]. The wobble sign allows differentiation of an epidermal, keratinocytic lesion from a lesion with a dermal component (eg, a compound or intradermal nevus).</p><p></p><p>Solar lentigo usually reveals fingerprint-like structures, sharp and well-demarcated borders, and moth-eaten borders.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical-dermoscopic</strong> <strong>variants</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Heavily pigmented seborrheic keratoses (melanoacanthoma)</strong> – Heavily pigmented seborrheic keratoses can display a blue-white veil. Some clues to help differentiate the blue-white veil in a seborrheic keratosis from a melanoma include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A seborrheic keratosis will not display any other melanoma-specific structures (eg, streaks; atypical network; angulated lines; negative network; shiny, white lines; atypical dots; and globules) [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Within the blue-white veil of a seborrheic keratosis, one will almost always see multiple comedo-like openings.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The wobble test, in which the seborrheic keratosis lesion will slide en bloc, whereas a melanoma will not and will wobble instead [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lichen planus-like keratosis</strong> – Usually represents an involuting solar lentigo or seborrheic keratosis. Under dermoscopy, lichen planus-like keratoses can reveal regression structures (granularity/peppering). The presence of these structures may make it difficult to differentiate these lesions from melanoma. Clues that may help in the differential diagnosis include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Involution of lentigo/seborrheic keratosis usually occurs centripetally (ie, from the edge). Thus, a presumed lentigo or seborrheic keratosis revealing regression structures in the center, with the appearance of the peppering expanding centrifugally, should raise concern for melanoma.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In lesions that have not yet fully involuted, one can visualize classic features of lentigo/seborrheic keratosis at the edge opposite or lateral to the area of peppering.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The granularity in involuting lentigo/seborrheic keratosis tends to be coarser, and often, the granules appear to be clumped.</p><p></p><p class="headingAnchor" id="H22058009"><span class="h3">Other benign lesions</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Criteria for hemangioma/angioma, angiokeratoma, and lymphangioma</strong> – Red, maroon, purple, blue-black, or clear lagoons are the diagnostic criteria for hemangioma/angioma, angiokeratoma, and lymphangioma. These features are small, well-demarcated areas (often separated by septa), corresponding to dilated blood vessels in the dermis:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Angioma</strong> – The lacunae tend to have a red to maroon color. Thrombosed lacunae will have a black color  (<a class="graphic graphic_picture graphicRef66439" href="/d/graphic/66439.html" rel="external">picture 17</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Angiokeratoma</strong> – Lacunae with varying shades of red, maroon, and blue  (<a class="graphic graphic_picture graphicRef66439" href="/d/graphic/66439.html" rel="external">picture 17</a>). There may be thrombosed lacunae displaying a black color. The central portion of the lesion often has a blue-whitish veil, and the periphery often has an erythematous halo.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lymphangioma</strong> – Lacunae with a clear to slight yellowish color  (<a class="graphic graphic_picture graphicRef141524" href="/d/graphic/141524.html" rel="external">picture 18</a>). On occasion, there may be some blood present within a lymphangioma. The blood tends to settle to the bottom of the lacunae due to gravity, creating lacunae displaying two discrete tones (also called two-toned lacunae with the hyphema sign)  (<a class="graphic graphic_picture graphicRef141525" href="/d/graphic/141525.html" rel="external">picture 19</a>) [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sebaceous hyperplasia</strong> – Whitish/yellowish, globular or polyglobular structures with a resemblance to popcorn  (<a class="graphic graphic_picture graphicRef96288" href="/d/graphic/96288.html" rel="external">picture 20</a>). Crown vessels at the periphery of the lesion, which radiate towards the center but tend not to cross its midline. Molluscum contagiosum will manifest a similar pattern.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clear cell acanthoma</strong> – Dotted or glomerular vessels, arranged in a "string of pearls" pattern  (<a class="graphic graphic_picture graphicRef141522" href="/d/graphic/141522.html" rel="external">picture 1</a>).</p><p></p><p>Experienced clinicians can recognize other benign lesions (eg, poroma and xanthogranuloma) in this step.</p><p class="headingAnchor" id="H2314663759"><span class="h2">Step 2: Equivocal lesions</span><span class="headingEndMark"> — </span>Lesions that cannot be diagnosed with certainty as one of the benign lesions listed in step 1 will proceed to step 2 for further evaluation  (<a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>). In step 2, the observer will determine if the overall pattern of the lesion is organized or disorganized. Organization refers to the distribution of colors and structures within the lesion. Lesions displaying a disorganized pattern (ie, asymmetric, chaotic) are evaluated in step 2a, while lesions manifesting an organized pattern are evaluated in step 2b.</p><p class="headingAnchor" id="H4010232453"><span class="h3">Step 2a: Disorganized lesions</span></p><p class="headingAnchor" id="H1583336416"><span class="h4">General considerations</span><span class="headingEndMark"> — </span>In general, disorganized lesions will prove to be cancer or cancer mimickers  (<a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>The most common diagnosable cancers are BCC, SCC, and melanoma.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>More rare skin malignancies (eg, Merkel cell carcinoma, sebaceous carcinoma, porocarcinoma) will also often appear disorganized. Although no structure or combination of structures can definitively diagnose these rare cancers via dermoscopy, some clues such as color, presence of certain dermoscopic structures (eg, polylobular structures in sebaceous carcinoma or looped vessels with rounded endings in porocarcinoma), and location of the tumor may suggest a specific rare cancer diagnosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some benign lesions (eg, a subset of dysplastic nevi, spitzoid nevi, BAP1-inactivated melanocytomas) can manifest a disorganized pattern that mimics melanoma. Because dermoscopy cannot discriminate them from melanoma, these lesions need to be biopsied for a correct diagnosis. With all the caveats mentioned above, step 2a focuses on correctly identifying BCC, SCC, and melanoma while not missing other less common skin malignancies.</p><p></p><p class="headingAnchor" id="H610193"><span class="h4">Criteria for basal cell carcinoma</span><span class="headingEndMark"> — </span>The diagnostic criteria for BCC include the lack of a pigment network and the presence of at least one positive feature for BCC  (<a class="graphic graphic_figure graphicRef66887" href="/d/graphic/66887.html" rel="external">figure 3</a> and <a class="graphic graphic_picture graphicRef61313" href="/d/graphic/61313.html" rel="external">picture 21</a> and <a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>) [<a href="#rid35">35</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonpigmented structures</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Arborizing vessels</p><p class="bulletIndent2"><span class="glyph">•</span>Ulceration and small erosions</p><p class="bulletIndent2"><span class="glyph">•</span>Shiny, white blotches and strands (seen with polarized dermoscopy) [<a href="#rid36">36</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Fine, short, superficial telangiectasias</p><p class="bulletIndent2"><span class="glyph">•</span>Multiple aggregated, yellowish-whitish globules</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pigmented structures</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Leaf-like areas</p><p class="bulletIndent2"><span class="glyph">•</span>Large, blue-gray, ovoid nests</p><p class="bulletIndent2"><span class="glyph">•</span>Multiple blue-gray, nonaggregated globules</p><p class="bulletIndent2"><span class="glyph">•</span>Spoke-wheel structures, including concentric globules</p><p class="bulletIndent2"><span class="glyph">•</span>Multiple in-focus, fine brown to gray dots</p><p class="bulletIndent2"><span class="glyph">•</span>Blue-gray dots in a bird shot scatter distribution</p><p></p><p class="headingAnchor" id="H10484662"><span class="h4">Criteria for cutaneous squamous cell carcinoma</span><span class="headingEndMark"> — </span>The diagnostic criteria for cutaneous squamous cell carcinoma (cSCC) include  (<a class="graphic graphic_figure graphicRef90878" href="/d/graphic/90878.html" rel="external">figure 4</a> and <a class="graphic graphic_picture graphicRef90936 graphicRef90937" href="/d/graphic/90936.html" rel="external">picture 22A-B</a> and <a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>) [<a href="#rid37">37-39</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Glomerular or coiled vessels, usually focally distributed towards the periphery of the lesion but can also be diffusely present throughout the lesion or in a linear fashion within the lesion</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rosettes (seen with polarized light)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>White circles or keratin pearls</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Yellow scale/rough texture</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Brown dots/globules aligned in straight, radially oriented lines, usually located towards the periphery</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Brown circles</p><p></p><p class="headingAnchor" id="H1154496653"><span class="h5">Variants</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Keratoacanthoma</strong> – Keratoacanthoma is a form of a well-differentiated cSCC with the potential to spontaneously involute. Clinically, keratoacanthoma is characterized by a dome-shaped appearance with central scale/keratin. Dermoscopically, keratoacanthoma often reveals white circles; shiny, white blotches; and looped to twisted-looped (hairpin) vessels with a whitish halo at the periphery  (<a class="graphic graphic_picture graphicRef141523" href="/d/graphic/141523.html" rel="external">picture 23</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Actinic keratosis</strong> – Actinic keratosis contains cells similar to those seen in cSCC, but the cells tend not to encompass the entire thickness of the epidermis (as they do in unequivocal cSCC). Actinic keratoses reveal a rough texture on palpation. Some consider these lesions to be early cSCC but with the caveats that most do not progress to full thickness atypia and many can spontaneously involute. (See  <a class="medical medical_review" href="/d/html/13712.html" rel="external">"Actinic keratosis: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonpigmented actinic keratosis</strong> – Dermoscopy features include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Strawberry pattern – Consists of prominent, white, follicular openings with or without rosettes and perifollicular erythema [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Occasionally, some actinic keratoses display large areas with adherent scale-crust (hypertrophic actinic keratosis) and dotted or glomerular vessels. In such lesions, it is almost impossible to differentiate them from full thickness cSCC cancers.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pigmented actinic keratosis</strong> – Pigmented actinic keratosis usually results from the collision of an actinic keratosis with a solar lentigo. These lesions can be difficult to differentiate from lentigo maligna, but some clues include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Actinic keratosis will have a rough texture, whereas lentigo maligna will have a smooth surface.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The follicular (adnexal/ostial) openings in actinic keratosis tend to be large, whitish, and uniformly distributed. In lentigo maligna, the follicular openings will be of variable size, with asymmetric distribution of pigment (often with grayish hues), follicles surrounded by gray dots, and adnexal openings not uniformly distributed.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Actinic keratoses will often have many rosettes, whereas lentigo maligna will have few to no rosettes.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Both pigmented actinic keratosis and lentigo maligna can reveal structures that look like angulated lines. However, unlike lentigo maligna, the angulated lines in pigmented actinic keratosis are due to keratin and, thus, will have a brownish color and a rough texture. In lentigo maligna, the angulated lines will not have a rough texture but will often have grayish tones.</p><p></p><p class="bulletIndent1">The aforementioned clues usually help differentiate a pigmented actinic keratosis from lentigo maligna. However, at times it can be impossible, and a biopsy or evaluation with reflectance confocal microscopy will be required. Also, it is important to remember that it is not uncommon to find collision lesions, resulting from pigmented actinic keratosis and lentigo maligna, on areas of sun-damaged skin.</p><p></p><p class="headingAnchor" id="H2463755450"><span class="h4">Criteria for melanoma</span><span class="headingEndMark"> — </span>The dermoscopic melanoma-specific structures consist of  (<a class="graphic graphic_picture graphicRef79576 graphicRef60407 graphicRef73202 graphicRef51173" href="/d/graphic/79576.html" rel="external">picture 24A-D</a> and <a class="graphic graphic_table graphicRef74394" href="/d/graphic/74394.html" rel="external">table 1</a> and <a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Atypical network.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Angulated lines.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Streaks (ie, pseudopods and radial streaming).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Negative network.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Off-centered blotch.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Atypical dots and/or globules.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Regression structures, including granularity (also known as peppering) and scar-like areas. The presence of granularity and scar-like areas within the same lesion results in the appearance of a blue-white coloration, usually overlying macular areas.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blue-white veil overlying raised areas.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Atypical, vascular structures.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Shiny, white lines (formerly known as crystalline structures).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tan, peripheral, structureless areas.</p><p></p><p class="headingAnchor" id="H3522796588"><span class="h3">Step 2b: Organized lesions</span><span class="headingEndMark"> — </span>Step 2b is reserved for lesions that are not unequivocally benign (as listed in step 1) and manifest an organized architectural morphology on dermoscopy  (<a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>). In such lesions, it is imperative not to miss a malignancy displaying an organized pattern, such as rare and uncommon tumors (eg, Merkel cell carcinoma, leiomyosarcoma, nodular melanoma, nevoid melanoma, desmoplastic melanoma, spitzoid amelanotic melanoma, epidermotropic metastasis, featureless/structureless/feature-poor melanoma).</p><p class="bulletIndent1"><span class="glyph">●</span>Any organized lesion manifesting <strong>any of two patterns, two structures, or four colors</strong> should be biopsied [<a href="#rid10">10,41</a>]: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patterns</strong> – Starburst pattern, negative network</p><p class="bulletIndent2"><span class="glyph">•</span><strong>Structures</strong> – Vessels, ulceration</p><p class="bulletIndent2"><span class="glyph">•</span><strong>Colors</strong> – Blue, black, gray, white</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitoring is reserved only for lesions that are flat (not palpable). Digital monitoring entails taking a baseline dermoscopy image of the lesion, which is then compared with a new image taken three to four months later. Images should be of good quality to be compared side by side. If there is any change (except in the number of milia cysts or pigmentation due to ultraviolet [UV] exposure), a skin biopsy should be considered. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other technologies, such as confocal microscopy, electrical impedance spectroscopy, and gene expression profiling via tape stripping of cells off the stratum corneum, may assist in managing these lesions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Palpable lesions with the above-mentioned features should <strong>never</strong> be subjected to monitoring and should always be biopsied to rule out a nodular melanoma. </p><p></p><p>The rules presented so far in the two-step algorithm can be applied to any lesion on the skin. However, additional dermoscopic criteria exist for lesions located on special sites, including facial skin and the glabrous areas (including the palms, soles, nails, and mucosae). (See  <a class="medical medical_review" href="/d/html/93602.html" rel="external">"Dermoscopy of facial lesions"</a> and  <a class="medical medical_review" href="/d/html/16551.html" rel="external">"Dermoscopy of pigmented lesions of the palms and soles"</a> and  <a class="medical medical_review" href="/d/html/100032.html" rel="external">"Dermoscopy of nail pigmentations"</a> and  <a class="medical medical_review" href="/d/html/93603.html" rel="external">"Dermoscopy of mucosal lesions"</a> and  <a class="medical medical_review" href="/d/html/100033.html" rel="external">"Dermoscopy of nonpigmented nail lesions"</a>.)</p><p class="headingAnchor" id="H18480302"><span class="h1">OTHER ALGORITHMS AND METHODS</span><span class="headingEndMark"> — </span>It should be underscored that the revised two-step process  (<a class="graphic graphic_algorithm graphicRef140579" href="/d/graphic/140579.html" rel="external">algorithm 2</a>) does not completely negate the usefulness of the original two-step algorithm  (<a class="graphic graphic_algorithm graphicRef62532" href="/d/graphic/62532.html" rel="external">algorithm 1</a>) [<a href="#rid9">9</a>]. Some clinicians still prefer to first segregate lesions into melanocytic and nonmelanocytic lesions. Lesions displaying network; streaks; angulated lines; negative network; aggregated globules; homogeneous, blue color; pseudonetwork; or parallel pattern on palms/soles would be classified as melanocytic lesions.</p><p>Additional algorithms and methods that aid the observer in differentiating nevi from melanoma include [<a href="#rid2">2,5,42-46</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>ABCD (<strong>a</strong>symmetry, <strong>b</strong>order sharpness, <strong>c</strong>olors, <strong>d</strong>ifferential dermoscopic structures) rule of dermoscopy  (<a class="graphic graphic_table graphicRef57741" href="/d/graphic/57741.html" rel="external">table 2</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Menzies method  (<a class="graphic graphic_table graphicRef66385" href="/d/graphic/66385.html" rel="external">table 3</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The seven-point checklist  (<a class="graphic graphic_table graphicRef60378" href="/d/graphic/60378.html" rel="external">table 4</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CASH (color, architectural disorder, symmetry, homogeneity/heterogeneity of dermoscopic structures) algorithm  (<a class="graphic graphic_table graphicRef59435" href="/d/graphic/59435.html" rel="external">table 5</a>)</p><p></p><p>Although all methods have a similar sensitivity  (<a class="graphic graphic_table graphicRef69408" href="/d/graphic/69408.html" rel="external">table 6</a>), pattern analysis has a superior specificity compared with the other quantitative scoring systems and is the method preferred by most experienced clinicians [<a href="#rid5">5,47</a>]. Novices in dermoscopy will benefit from quantitative methods such as the dermoscopy ABCD rule, Menzies method, and the seven-point checklist, which are relatively simple, accurate, and reproducible [<a href="#rid44">44,48,49</a>]. </p><p>Online tutorials on dermoscopy can be found at <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fdermoscopedia.org%2FMain_Page&amp;token=PsuzyVLnmOAjkubb%2F69SaSnNS500hqRN9%2BOMTvE8ud1XAgQ70IkEeXB6EHJODPsK&amp;TOPIC_ID=13522" target="_blank">www.dermoscopedia.org</a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fdermnetnz.org%2Fcme%2Fdermoscopy-course%2Fintroduction-to-dermoscopy&amp;token=OHHThLviXfXmhv3Rqe6NCdS6mJHjCq84eFzFGGoVdjNGTUzz2%2BNU9e%2BiPlu2e4PJz4qJg2nrdSDepC91GBJv6S7r9XAN9GCbB9lA%2BIS9FqU%3D&amp;TOPIC_ID=13522" target="_blank">www.dermnetnz.org/doctors/dermoscopy-course/introduction.html</a>, and <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.genomel.org%2Fdermoscopy&amp;token=7%2BGJrCvx%2FpgnT2Hm8UDNmEDTjwwyfSzIYVqt3D7apLUBK0x1255p8%2BIUGkc8b%2FGh&amp;TOPIC_ID=13522" target="_blank">www.genomel.org/dermoscopy</a>.</p><p class="headingAnchor" id="H18480310"><span class="h2">ABCD rule of dermoscopy</span><span class="headingEndMark"> — </span>The ABCD rule of dermoscopy is a semiquantitative scoring system that employs four dermoscopic criteria to evaluate a pigmented lesion: asymmetry, border sharpness, colors, and differential dermoscopic structures  (<a class="graphic graphic_table graphicRef57741" href="/d/graphic/57741.html" rel="external">table 2</a>) [<a href="#rid42">42</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asymmetry</strong> – Asymmetry refers to the contour and distribution of colors and structures within the lesion in none, one, or two perpendicular axes  (<a class="graphic graphic_figure graphicRef79218" href="/d/graphic/79218.html" rel="external">figure 5</a>). The score for asymmetry ranges between zero and two points. The ABCD rule of dermoscopy and the CASH algorithm are the only algorithms that take into account both contour and distribution of colors and structures.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Border sharpness</strong> – The border is evaluated for the presence of abrupt cutoffs between the lesion and the normal skin. The lesion is divided into a virtual pie with eight sections. For each segment presenting with an abrupt cutoff of pigment, a score of 1 is assigned. Hence, the border scoring ranges between zero and eight points.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Colors</strong> – Presence of any of six colors within the lesion: white, red, light brown, dark brown, blue-gray, and black. The score for color ranges from one to six points.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential dermoscopic structures</strong> – Presence of any of five structures including pigment network, homogeneous/structureless areas greater than 10 percent of the lesion (ie, hypopigmented or hyperpigmented blotches and depigmented or scar-like areas), branched streaks, dots, and globules. The score for dermoscopic structures ranges between one and five points.</p><p></p><p>The scores assigned to each feature are multiplied by a weighted factor and summed up in a final dermoscopy score. Sensitivity ranges from 78 to 90 percent and specificity ranges from 45 to 90 percent among experts and nonexperts [<a href="#rid5">5,7,42,44,45,49-54</a>].</p><p class="headingAnchor" id="H18480317"><span class="h2">Menzies method</span><span class="headingEndMark"> — </span>The Menzies method was originally developed to differentiate invasive melanomas from other pigmented lesions  (<a class="graphic graphic_table graphicRef66385" href="/d/graphic/66385.html" rel="external">table 3</a>) [<a href="#rid55">55</a>]. The method is based upon the evaluation of two negative features with a low sensitivity for melanoma (0 percent) and nine positive features with a high specificity for melanoma (&gt;85 percent).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Negative features</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symmetry of the pigmentation pattern</p><p class="bulletIndent2"><span class="glyph">•</span>Presence of only one color (black, gray, blue, red, dark brown, or tan)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Positive features</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Blue-white veil</p><p class="bulletIndent2"><span class="glyph">•</span>Multiple brown dots</p><p class="bulletIndent2"><span class="glyph">•</span>Pseudopods</p><p class="bulletIndent2"><span class="glyph">•</span>Radial streaming</p><p class="bulletIndent2"><span class="glyph">•</span>Scar-like depigmentation</p><p class="bulletIndent2"><span class="glyph">•</span>Peripheral, black dots/globules</p><p class="bulletIndent2"><span class="glyph">•</span>Broadened network</p><p class="bulletIndent2"><span class="glyph">•</span>Multiple blue/gray dots</p><p class="bulletIndent2"><span class="glyph">•</span>Multiple (five to six) colors</p><p></p><p>The presence of both negative features virtually excludes the diagnosis of melanoma. For all other lesions, the presence of any one of the positive features raises the suspicion for melanoma. The Menzies method has a sensitivity of 85 to 92 percent and a specificity of 38 to 78 percent among examiners with various degrees of experience [<a href="#rid5">5,7,45,50,53,55,56</a>].</p><p class="headingAnchor" id="H18480324"><span class="h2">The seven-point checklist</span><span class="headingEndMark"> — </span>The seven-point checklist is based upon seven dermoscopic features frequently associated with melanoma  (<a class="graphic graphic_table graphicRef60378" href="/d/graphic/60378.html" rel="external">table 4</a>) [<a href="#rid44">44</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Major criteria</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Atypical pigment network</p><p class="bulletIndent2"><span class="glyph">•</span>Blue-whitish veil</p><p class="bulletIndent2"><span class="glyph">•</span>Atypical, vascular pattern</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Minor criteria</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Irregular streaks</p><p class="bulletIndent2"><span class="glyph">•</span>Irregular dots/globules</p><p class="bulletIndent2"><span class="glyph">•</span>Irregular blotches</p><p class="bulletIndent2"><span class="glyph">•</span>Regression structures</p><p></p><p>A score is calculated by summing points, allotted as two points for each of the three major criteria and one point for each of the four minor criteria. A final score of 3 or more suggests melanoma [<a href="#rid44">44</a>]. The seven-point checklist has a sensitivity of 62 to 95 percent and a specificity of 35 to 97 percent among experts and nonexperts [<a href="#rid5">5,7,44,50-52,54,55,57</a>].</p><p>The presence of any one of the criteria has been proposed as sufficient to warrant a biopsy in a revised version of this checklist [<a href="#rid57">57</a>]. This revised seven-point checklist lowered the threshold for biopsy, using a total score of 1 (instead of 3) as sufficient to warrant a biopsy. Although this revision increased the sensitivity of the criteria, the authors acknowledge that the most sensitive and specific method to diagnose melanoma requires supportive evidence based on clinical characteristics, follow-up, and the comparative approach [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H18480338"><span class="h2">CASH algorithm</span><span class="headingEndMark"> — </span>CASH is an acronym for color, architectural disorder, symmetry, and homogeneity/heterogeneity of dermoscopic structures  (<a class="graphic graphic_table graphicRef59435" href="/d/graphic/59435.html" rel="external">table 5</a>) [<a href="#rid45">45</a>].</p><p>This method is based upon evaluating a pigmented lesion for the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of few versus many colors </p><p class="bulletIndent1"><span class="glyph">●</span>Architectural order versus disorder </p><p class="bulletIndent1"><span class="glyph">●</span>Symmetry of shape and pattern versus asymmetry </p><p class="bulletIndent1"><span class="glyph">●</span>Homogeneity versus heterogeneity of dermoscopic structures</p><p></p><p>The scoring system for the CASH algorithm is shown in a table  (<a class="graphic graphic_table graphicRef59435" href="/d/graphic/59435.html" rel="external">table 5</a>). A total CASH score of 8 or more is suspicious of melanoma (range 2 to 17) [<a href="#rid45">45</a>]. A score of 8 was chosen as a threshold that optimizes sensitivity and specificity for individuals with all levels of experience. However, a lower threshold for lesion excision may be appropriate for novices. The CASH algorithm has a sensitivity of 87 to 98 percent and a specificity of 67 to 68 percent [<a href="#rid45">45,59</a>].</p><p class="headingAnchor" id="H18480352"><span class="h1">DERMOSCOPY FROM A MANAGEMENT PERSPECTIVE</span></p><p class="headingAnchor" id="H2462456686"><span class="h2">Determining whether a lesion should be biopsied</span><span class="headingEndMark"> — </span>The primary purpose of examining a skin lesion with a dermatoscope is to determine whether the lesion should be biopsied or not [<a href="#rid60">60</a>]. The decision to biopsy a suspicious lesion should be based upon the combination of the clinical and dermoscopic examination of the lesion in question as well as surrounding lesions (comparative approach) and other relevant information (ie, context), including history of change, associated symptoms, skin type, location, and personal and family history of melanoma and other skin cancers. </p><p>In patients with multiple nevi, it is useful to identify the "signature nevus" pattern (the predominant type of nevus) as well as lesions that deviate from the predominant pattern ("ugly duckling" lesions) both clinically and dermoscopically [<a href="#rid61">61,62</a>]. A comparative dermoscopic approach to the patient with multiple nevi reduces the number of excisions of benign nevi [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/d/html/15806.html" rel="external">"Melanoma: Clinical features and diagnosis", section on 'The 'ugly duckling' sign'</a>.)</p><p>After a complete clinical and dermoscopic examination utilizing the revised two-step dermoscopy algorithm, a management decision can be rendered:</p><p class="bulletIndent1"><span class="glyph">●</span>If the lesion is considered to be <strong>unequivocally</strong> benign  (<a class="graphic graphic_algorithm graphicRef140579" href="/d/graphic/140579.html" rel="external">algorithm 2</a>), the patient can be reassured, educated on the importance of skin self-examination, and instructed to return if changes are detected [<a href="#rid63">63,64</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the lesion is considered to be a melanoma or other skin malignancy  (<a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>), it should undergo excisional biopsy and histopathologic examination [<a href="#rid65">65-68</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the lesion is considered suspicious or undetermined, there are two options: Perform a biopsy or refer the patient to an expert clinician for further evaluation.</p><p></p><p>The management decision will depend on several factors, including the pretest probability of the diagnosis of the lesion. For example, a lesion with a spitzoid morphology in a child is less likely to be a melanoma than a similar lesion in an adult. (See  <a class="medical medical_review" href="/d/html/129823.html" rel="external">"Spitz nevus/tumor in children: Diagnosis and management"</a>.)</p><p>Based on the pretest probability, the clinician may be more likely to biopsy spitzoid lesions in adults than in children. Other factors that may influence the management decision include whether or not the lesion is an isolated lesion or one in a sea of many nevi and whether or not the lesion is a clinical or dermoscopic outlier lesion.</p><p>Lesions referred to an expert for further evaluation may be deemed benign, biopsied, or subjected to short-term monitoring. The rationale behind short-term monitoring is that stable lesions are biologically indolent and represent nevi, whereas changing lesions are biologically dynamic and may be atypical nevi or melanoma [<a href="#rid69">69,70</a>].</p><p class="headingAnchor" id="H1611779104"><span class="h2">Short-term dermoscopic monitoring</span><span class="headingEndMark"> — </span>Short-term dermoscopic monitoring, which consists of comparing digital dermoscopic images of the same lesion taken approximately three to four months apart, should ideally be performed in specialized centers by experienced clinicians [<a href="#rid69">69-71</a>]. This type of monitoring is only suitable for macular (nonpalpable) lesions; suspicious or atypical, nodular (palpable) lesions should be biopsied.</p><p>Short-term dermoscopic monitoring is a safe and accepted approach to monitor these flat (nonpalpable), atypical lesions. In one study, 19 percent of 318 nevi showed a change during this time period (2.5 to 4.5 months), and 11 percent of those changing lesions were found to be early melanomas [<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H3808408191"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/123052.html" rel="external">"Society guideline links: Dermoscopy"</a>.)</p><p class="headingAnchor" id="H6074417"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/83445.html" rel="external">"Patient education: Seborrheic keratosis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H440328"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Principles of dermoscopic diagnosis</strong> – Dermoscopic diagnosis of skin lesions involves the recognition of the presence or absence of specific structures to confirm or rule out a given diagnosis. From a cognitive perspective, this task may be accomplished using a bottom-up or a top-down strategy. (See <a class="local">'Principles of dermoscopic diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/13521.html" rel="external">"Overview of dermoscopy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>The revised two-step pattern analysis algorithm</strong> – The revised version of the two-step pattern analysis algorithm eliminates the former requirement to differentiate melanocytic from nonmelanocytic lesions in the first step  (<a class="graphic graphic_algorithm graphicRef140579" href="/d/graphic/140579.html" rel="external">algorithm 2</a>). (See <a class="local">'Pattern analysis: The revised two-step algorithm for skin lesion evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Step 1</strong> – In the first step, the observer is required to make a specific diagnosis by recognizing the patterns associated with common, benign neoplasms (eg, nevi, lentigines, seborrheic keratoses, angiomas)  (<a class="graphic graphic_algorithm graphicRef140580" href="/d/graphic/140580.html" rel="external">algorithm 3</a>). If an unequivocal diagnosis of one of the benign lesions cannot be made with confidence during step 1, then the lesion under evaluation will proceed to step 2. (See <a class="local">'Step 1: Benign lesions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Step 2</strong> – In the second step, the observer will determine if the overall pattern of the lesion (ie, distribution of colors and structures) is organized or disorganized  (<a class="graphic graphic_algorithm graphicRef140585" href="/d/graphic/140585.html" rel="external">algorithm 4</a>). Lesions displaying a disorganized pattern (ie, asymmetric or chaotic) are evaluated in step 2a, and lesions manifesting an organized pattern are evaluated in step 2b. (See <a class="local">'Step 2: Equivocal lesions'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Lesions displaying a disorganized pattern have a high likelihood of being malignant, and based on the presence of specific structures, these lesions are subclassified as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or melanoma in most cases.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Lesions displaying an organized pattern are likely benign. However, organized lesions should still raise concern for malignancy if they display any of the following: starburst pattern; negative network pattern; vessels; ulceration; or blue-black, gray, or white color.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other algorithms</strong> – Other algorithms can be used to differentiate nevi from melanoma. Clinicians with limited experience in dermoscopy may benefit from quantitative methods, such as the ABCD (<strong>a</strong>symmetry, <strong>b</strong>order sharpness, <strong>c</strong>olors, <strong>d</strong>ifferential dermoscopic structures) rule, the Menzies method, and the seven-point checklist. These methods are relatively simple, accurate, and reproducible. (See <a class="local">'ABCD rule of dermoscopy'</a> above and <a class="local">'Menzies method'</a> above and <a class="local">'The seven-point checklist'</a> above and <a class="local">'CASH algorithm'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management implications</strong> – If a lesion is considered benign after a thorough clinical and dermoscopic examination, the patient can be reassured and educated on the importance of skin self-examination and instructed to return if changes occur. A lesion that shows dermoscopic features of melanoma or other skin cancers should be excised and sent for histopathologic examination. If a lesion is considered suspicious, it should be biopsied, or the patient should be referred to an expert clinician for further evaluation and monitoring. (See <a class="local">'Dermoscopy from a management perspective'</a> above.)</p><p></p><p class="bulletIndent1">Short-term dermoscopic monitoring (ie, comparison of digital dermoscopic images of the same lesion taken approximately three to four months apart) should ideally be performed in specialized centers by experienced clinicians. (See <a class="local">'Short-term dermoscopic monitoring'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Marghoob AA, Swindle LD, Moricz CZ, et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol 2003; 49:777.</a></li><li><a class="nounderline abstract_t">Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res 1996; 6:55.</a></li><li><a class="nounderline abstract_t">Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions--a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001; 2:443.</a></li><li><a class="nounderline abstract_t">Wolfe JM, Butcher SJ, Lee C, Hyle M. Changing your mind: on the contributions of top-down and bottom-up guidance in visual search for feature singletons. J Exp Psychol Hum Percept Perform 2003; 29:483.</a></li><li><a class="nounderline abstract_t">Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48:679.</a></li><li><a class="nounderline abstract_t">Marghoob AA, Braun R. Proposal for a revised 2-step algorithm for the classification of lesions of the skin using dermoscopy. Arch Dermatol 2010; 146:426.</a></li><li><a class="nounderline abstract_t">Blum A, Clemens J, Argenziano G. Modified dermoscopic algorithm for the differentiation between melanocytic and nonmelanocytic skin tumors. J Cutan Med Surg 2006; 10:73.</a></li><li><a class="nounderline abstract_t">Kittler H. Why the first step should be abandoned! Arch Dermatol 2010; 146:1182.</a></li><li><a class="nounderline abstract_t">Chen LL, Dusza SW, Jaimes N, Marghoob AA. Performance of the First Step of the 2-Step Dermoscopy Algorithm. JAMA Dermatol 2015; 151:715.</a></li><li><a class="nounderline abstract_t">Jaimes N, Marghoob AA. Triage amalgamated dermoscopic algorithm. J Am Acad Dermatol 2020; 82:1551.</a></li><li><a class="nounderline abstract_t">Rogers T, Marino M, Dusza SW, et al. Triage amalgamated dermoscopic algorithm (TADA) for skin cancer screening. Dermatol Pract Concept 2017; 7:39.</a></li><li><a class="nounderline abstract_t">Jaimes N, Marghoob AA, Rabinovitz H, et al. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin. J Am Acad Dermatol 2015; 72:1027.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Docimo G, Argenziano G. Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol 2009; 145:816.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Schmid K, Marghoob AA, et al. Frequency of dermoscopic nevus subtypes by age and body site: a cross-sectional study. Arch Dermatol 2011; 147:663.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Grinschgl S, Argenziano G, et al. Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi. Br J Dermatol 2006; 154:299.</a></li><li><a class="nounderline abstract_t">Scope A, Marchetti MA, Marghoob AA, et al. The study of nevi in children: Principles learned and implications for melanoma diagnosis. J Am Acad Dermatol 2016; 75:813.</a></li><li><a class="nounderline abstract_t">Scope A, Marghoob AA, Dusza SW, et al. Dermoscopic patterns of naevi in fifth grade children of the Framingham school system. Br J Dermatol 2008; 158:1041.</a></li><li><a class="nounderline abstract_t">Kerner M, Jaimes N, Scope A, Marghoob AA. Spitz nevi: a bridge between dermoscopic morphology and histopathology. Dermatol Clin 2013; 31:327.</a></li><li><a class="nounderline abstract_t">Reiter O, Chousakos E, Kurtansky N, et al. Association between the dermoscopic morphology of peripheral globules and melanocytic lesion diagnosis. J Eur Acad Dermatol Venereol 2021; 35:892.</a></li><li><a class="nounderline abstract_t">Bajaj S, Dusza SW, Marchetti MA, et al. Growth-Curve Modeling of Nevi With a Peripheral Globular Pattern. JAMA Dermatol 2015; 151:1338.</a></li><li><a class="nounderline abstract_t">Williams NM, Navarrete-Dechent C, Marchetti MA, et al. Diagnostic utility of circumferential peripheral globules under dermoscopy in adults. J Am Acad Dermatol 2021; 85:1300.</a></li><li><a class="nounderline abstract_t">Moraes AFA, Blumetti TCMP, Pinto C, et al. Melanoma with peripheral globules: Clinical and dermatoscopic features. J Am Acad Dermatol 2022; 87:567.</a></li><li><a class="nounderline abstract_t">Lallas A, Apalla Z, Ioannides D, et al. Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society. Br J Dermatol 2017; 177:645.</a></li><li><a class="nounderline abstract_t">Costa J, Ortiz-Ibañez K, Salerni G, et al. Dermoscopic patterns of melanoma metastases: interobserver consistency and accuracy for metastasis recognition. Br J Dermatol 2013; 169:91.</a></li><li><a class="nounderline abstract_t">Kittler H, Guitera P, Riedl E, et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol 2006; 142:1113.</a></li><li><a class="nounderline abstract_t">Argenziano G, Catricalà C, Ardigo M, et al. Dermoscopy of patients with multiple nevi: Improved management recommendations using a comparative diagnostic approach. Arch Dermatol 2011; 147:46.</a></li><li><a class="nounderline abstract_t">Grazzini M, Marghoob AA. The "golden brown halo" of the Miescher nevus. Arch Dermatol 2012; 148:870.</a></li><li><a class="nounderline abstract_t">Greco V, Cappello M, Megna M, et al. Dermoscopic patterns of intradermal naevi. Australas J Dermatol 2020; 61:337.</a></li><li><a class="nounderline abstract_t">Niederkorn A, Ahlgrimm-Siess V, Fink-Puches R, et al. Frequency, clinical and dermoscopic features of benign papillomatous melanocytic naevi (Unna type). Br J Dermatol 2009; 161:510.</a></li><li><a class="nounderline abstract_t">Williams NM, Navarrete-Dechent C, Marghoob AA, et al. Differentiating basal cell carcinoma from intradermal nevi along the eyelid margin with dermoscopy: A case series. J Am Acad Dermatol 2021; 84:173.</a></li><li><a class="nounderline abstract_t">Braun RP, Krischer J, Saurat JH. The "wobble sign" in epiluminescence microscopy as a novel clue to the differential diagnosis of pigmented skin lesions. Arch Dermatol 2000; 136:940.</a></li><li><a class="nounderline abstract_t">Braun RP, Rabinovitz HS, Krischer J, et al. Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol 2002; 138:1556.</a></li><li><a class="nounderline abstract_t">Carrera C, Segura S, Aguilera P, et al. Dermoscopic Clues for Diagnosing Melanomas That Resemble Seborrheic Keratosis. JAMA Dermatol 2017; 153:544.</a></li><li><a class="nounderline abstract_t">Zaballos P, Del Pozo LJ, Argenziano G, et al. Dermoscopy of lymphangioma circumscriptum: A morphological study of 45 cases. Australas J Dermatol 2018; 59:e189.</a></li><li><a class="nounderline abstract_t">Menzies SW, Westerhoff K, Rabinovitz H, et al. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000; 136:1012.</a></li><li><a class="nounderline abstract_t">Navarrete-Dechent C, Bajaj S, Marchetti MA, et al. Association of Shiny White Blotches and Strands With Nonpigmented Basal Cell Carcinoma: Evaluation of an Additional Dermoscopic Diagnostic Criterion. JAMA Dermatol 2016; 152:546.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Giacomel J, Schmid K, et al. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J Am Acad Dermatol 2012; 66:589.</a></li><li><a class="nounderline abstract_t">Jaimes N, Zalaudek I, Braun RP, et al. Pearls of keratinizing tumors. Arch Dermatol 2012; 148:976.</a></li><li><a class="nounderline abstract_t">Rosendahl C, Cameron A, Argenziano G, et al. Dermoscopy of squamous cell carcinoma and keratoacanthoma. Arch Dermatol 2012; 148:1386.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Giacomel J, Argenziano G, et al. Dermoscopy of facial nonpigmented actinic keratosis. Br J Dermatol 2006; 155:951.</a></li><li><a class="nounderline abstract_t">Rogers T, Marino ML, Dusza SW, et al. A Clinical Aid for Detecting Skin Cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA). J Am Board Fam Med 2016; 29:694.</a></li><li><a class="nounderline abstract_t">Stolz W, Riemann, A Cognetta AB, et al. ABCD rule of dermoscopy: a new practical method for early recognition of maligant melanoma. Eur J Dermatol 1994; 4:521.</a></li><li><a class="nounderline abstract_t">Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol 1987; 17:571.</a></li><li><a class="nounderline abstract_t">Argenziano G, Fabbrocini G, Carli P, et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998; 134:1563.</a></li><li><a class="nounderline abstract_t">Henning JS, Dusza SW, Wang SQ, et al. The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy. J Am Acad Dermatol 2007; 56:45.</a></li><li><a class="nounderline abstract_t">Soyer HP, Argenziano G, Zalaudek I, et al. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology 2004; 208:27.</a></li><li><a class="nounderline abstract_t">Carrera C, Marchetti MA, Dusza SW, et al. Validity and Reliability of Dermoscopic Criteria Used to Differentiate Nevi From Melanoma: A Web-Based International Dermoscopy Society Study. JAMA Dermatol 2016; 152:798.</a></li><li><a class="nounderline abstract_t">Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3:159.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Argenziano G, Soyer HP, et al. Three-point checklist of dermoscopy: an open internet study. Br J Dermatol 2006; 154:431.</a></li><li><a class="nounderline abstract_t">Dolianitis C, Kelly J, Wolfe R, Simpson P. Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions. Arch Dermatol 2005; 141:1008.</a></li><li><a class="nounderline abstract_t">Annessi G, Bono R, Sampogna F, et al. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas. J Am Acad Dermatol 2007; 56:759.</a></li><li><a class="nounderline abstract_t">Carli P, Quercioli E, Sestini S, et al. Pattern analysis, not simplified algorithms, is the most reliable method for teaching dermoscopy for melanoma diagnosis to residents in dermatology. Br J Dermatol 2003; 148:981.</a></li><li><a class="nounderline abstract_t">Pagnanelli G, Soyer HP, Argenziano G, et al. Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts. Br J Dermatol 2003; 148:698.</a></li><li><a class="nounderline abstract_t">Haenssle HA, Korpas B, Hansen-Hagge C, et al. Seven-point checklist for dermatoscopy: performance during 10 years of prospective surveillance of patients at increased melanoma risk. J Am Acad Dermatol 2010; 62:785.</a></li><li><a class="nounderline abstract_t">Menzies SW, Ingvar C, Crotty KA, McCarthy WH. Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Arch Dermatol 1996; 132:1178.</a></li><li><a class="nounderline abstract_t">Menzies SW, Kreusch J, Byth K, et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol 2008; 144:1120.</a></li><li><a class="nounderline abstract_t">Argenziano G, Catricalà C, Ardigo M, et al. Seven-point checklist of dermoscopy revisited. Br J Dermatol 2011; 164:785.</a></li><li><a class="nounderline abstract_t">Argenziano G, Kittler H, Ferrara G, et al. Slow-growing melanoma: a dermoscopy follow-up study. Br J Dermatol 2010; 162:267.</a></li><li><a class="nounderline abstract_t">Henning JS, Stein JA, Yeung J, et al. CASH algorithm for dermoscopy revisited. Arch Dermatol 2008; 144:554.</a></li><li><a class="nounderline abstract_t">Bystryn JC. Epiluminescence microscopy: a reevaluation of its purpose. Arch Dermatol 2001; 137:377.</a></li><li><a class="nounderline abstract_t">Suh KY, Bolognia JL. Signature nevi. J Am Acad Dermatol 2009; 60:508.</a></li><li><a class="nounderline abstract_t">Grob JJ, Bonerandi JJ. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol 1998; 134:103.</a></li><li><a class="nounderline abstract_t">Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol 2008; 144:502.</a></li><li><a class="nounderline abstract_t">Liu W, Hill D, Gibbs AF, et al. What features do patients notice that help to distinguish between benign pigmented lesions and melanomas?: the ABCD(E) rule versus the seven-point checklist. Melanoma Res 2005; 15:549.</a></li><li><a class="nounderline abstract_t">Ng PC, Barzilai DA, Ismail SA, et al. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth? J Am Acad Dermatol 2003; 48:420.</a></li><li><a class="nounderline abstract_t">Marsden JR, Newton-Bishop JA, Burrows L, et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg 2010; 63:1401.</a></li><li><a class="nounderline abstract_t">Coit DG, Andtbacka R, Bichakjian CK, et al. Melanoma. J Natl Compr Canc Netw 2009; 7:250.</a></li><li><a class="nounderline abstract_t">Bichakjian CK, Halpern AC, Johnson TM, et al. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol 2011; 65:1032.</a></li><li><a class="nounderline abstract_t">Menzies SW, Gutenev A, Avramidis M, et al. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol 2001; 137:1583.</a></li><li><a class="nounderline abstract_t">Argenziano G, Mordente I, Ferrara G, et al. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol 2008; 159:331.</a></li><li><a class="nounderline abstract_t">Fuller SR, Bowen GM, Tanner B, et al. Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg 2007; 33:1198.</a></li></ol></div><div id="topicVersionRevision">Topic 13522 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14576657" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Instruments and new technologies for the in vivo diagnosis of melanoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8640071" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11905739" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Dermoscopy of pigmented skin lesions--a valuable tool for early diagnosis of melanoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12760630" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Changing your mind: on the contributions of top-down and bottom-up guidance in visual search for feature singletons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12734496" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20404234" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Proposal for a revised 2-step algorithm for the classification of lesions of the skin using dermoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17241578" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Modified dermoscopic algorithm for the differentiation between melanocytic and nonmelanocytic skin tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20956665" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Why the first step should be abandoned!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25714607" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Performance of the First Step of the 2-Step Dermoscopy Algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32045619" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Triage amalgamated dermoscopic algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28515993" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Triage amalgamated dermoscopic algorithm (TADA) for skin cancer screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25824275" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19620566" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21690528" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Frequency of dermoscopic nevus subtypes by age and body site: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16433800" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27320410" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The study of nevi in children: Principles learned and implications for melanoma diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18363751" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Dermoscopic patterns of naevi in fifth grade children of the Framingham school system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23557659" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Spitz nevi: a bridge between dermoscopic morphology and histopathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33205467" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Association between the dermoscopic morphology of peripheral globules and melanocytic lesion diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26287475" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Growth-Curve Modeling of Nevi With a Peripheral Globular Pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32891776" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Diagnostic utility of circumferential peripheral globules under dermoscopy in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35487331" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Melanoma with peripheral globules: Clinical and dermatoscopic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28118479" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23495915" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Dermoscopic patterns of melanoma metastases: interobserver consistency and accuracy for metastasis recognition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16982998" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21242392" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Dermoscopy of patients with multiple nevi: Improved management recommendations using a comparative diagnostic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22801638" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The "golden brown halo" of the Miescher nevus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32715462" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Dermoscopic patterns of intradermal naevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19466956" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Frequency, clinical and dermoscopic features of benign papillomatous melanocytic naevi (Unna type).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32330634" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Differentiating basal cell carcinoma from intradermal nevi along the eyelid margin with dermoscopy: A case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10891009" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The "wobble sign" in epiluminescence microscopy as a novel clue to the differential diagnosis of pigmented skin lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12472342" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Dermoscopy of pigmented seborrheic keratosis: a morphological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28355453" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Dermoscopic Clues for Diagnosing Melanomas That Resemble Seborrheic Keratosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28752523" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Dermoscopy of lymphangioma circumscriptum: A morphological study of 45 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10926737" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Surface microscopy of pigmented basal cell carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26792406" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Association of Shiny White Blotches and Strands With Nonpigmented Basal Cell Carcinoma: Evaluation of an Additional Dermoscopic Diagnostic Criterion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21839538" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22911213" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pearls of keratinizing tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22986634" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Dermoscopy of squamous cell carcinoma and keratoacanthoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17034524" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Dermoscopy of facial nonpigmented actinic keratosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28076252" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A Clinical Aid for Detecting Skin Cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : ABCD rule of dermoscopy: a new practical method for early recognition of maligant melanoma</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3668002" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9875194" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17190620" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14730233" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Three-point checklist of dermoscopy. A new screening method for early detection of melanoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27074267" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Validity and Reliability of Dermoscopic Criteria Used to Differentiate Nevi From Melanoma: A Web-Based International Dermoscopy Society Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11902502" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Diagnostic accuracy of dermoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16445771" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Three-point checklist of dermoscopy: an open internet study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16103330" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17316894" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12786829" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pattern analysis, not simplified algorithms, is the most reliable method for teaching dermoscopy for melanoma diagnosis to residents in dermatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12752126" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20226567" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Seven-point checklist for dermatoscopy: performance during 10 years of prospective surveillance of patients at increased melanoma risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8859028" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18794455" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Dermoscopic evaluation of amelanotic and hypomelanotic melanoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21175563" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Seven-point checklist of dermoscopy revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19785607" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Slow-growing melanoma: a dermoscopy follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18427058" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : CASH algorithm for dermoscopy revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11255355" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Epiluminescence microscopy: a reevaluation of its purpose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19231649" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Signature nevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9449921" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18427044" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16314742" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : What features do patients notice that help to distinguish between benign pigmented lesions and melanomas?: the ABCD(E) rule versus the seven-point checklist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12637923" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20728418" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Revised UK guidelines for the management of cutaneous melanoma 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19401060" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Melanoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21868127" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11735708" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18510663" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17903152" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
